TrialBreast cancer research and treatment2013

Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.

Carol J Fabian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.